PR
HRMY icon

PSP Research’s Harmony Biosciences HRMY Stock Holding History

PSP Research’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$364K Sell
10,000
-4,283
-30% -$135K 0.19% 40
2026
Q1 		$400K Hold
14,283
– – 0.28% 48
2025
Q4 		$534K Buy
+14,283
New +$470K 0.47% 32

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PSP Research's HRMY Position: Q2 2026 in Review

PSP Research reduced its Harmony Biosciences (HRMY) stake by 30% in Q2 2026, selling an estimated $135K and leaving 10,000 shares worth $364K. The position accounts for 0.19% of the portfolio, ranked #40.

PSP Research first reported a position in HRMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $534K in Q4 2025. 326 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • PSP Research held 10,000 shares of Harmony Biosciences worth $364K as of Q2 2026.
  • PSP Research sold 4,283 Harmony Biosciences shares in Q2 2026, an estimated $135K.
  • Harmony Biosciences made up 0.19% of PSP Research's portfolio in Q2 2026, its #40 holding.
  • PSP Research first reported a position in Harmony Biosciences in Q4 2025 and has held it in 3 quarters since.
  • PSP Research's Harmony Biosciences position peaked at $534K in Q4 2025.
  • 326 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on PSP Research's 13F filing for Q2 2026, filed 9 Jul 2026.